These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 3002965)
1. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3. Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D affects proliferation of a murine T helper cell clone. Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220 [TBL] [Abstract][Full Text] [Related]
4. The influence of calciotrophic hormones on lymphocyte transformation and interleukin-2 production in human mononuclear cells. Smith J; Jenkins AS; Caine S; Boyle IT J Clin Lab Immunol; 1990 Oct; 33(2):49-54. PubMed ID: 1967065 [TBL] [Abstract][Full Text] [Related]
5. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160 [TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. Hale LV; Kemick ML; Wuthier RE J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742 [TBL] [Abstract][Full Text] [Related]
7. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat. Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782 [TBL] [Abstract][Full Text] [Related]
8. Effect of 1,25-dihydroxyvitamin D3 on prostaglandin E2 production in cultured mouse parietal bones. Klein-Nulend J; Pilbeam CC; Raisz LG J Bone Miner Res; 1991 Dec; 6(12):1339-44. PubMed ID: 1838853 [TBL] [Abstract][Full Text] [Related]
9. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Nunn JD; Katz DR; Barker S; Fraher LJ; Hewison M; Hendy GN; O'Riordan JL Immunology; 1986 Dec; 59(4):479-84. PubMed ID: 3026959 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect by 1,25-dihydroxyvitamin D3 on concanavalin A-stimulated proliferation of rat thymic lymphocytes. Kojima A; Hato F; Kinoshita Y; Nishizawa Y; Morii H Cell Mol Biol (Noisy-le-grand); 1992 Dec; 38(8):867-75. PubMed ID: 1477603 [TBL] [Abstract][Full Text] [Related]
12. [Metabolism of 25-hydroxyvitamin D3 and its regulation in rats during hypokinesis]. Sergeev IN; Arkhapchev IuP; Linberg LF; Blazheevich NV; Ushakov AS Biokhimiia; 1984 Apr; 49(4):590-8. PubMed ID: 6329324 [TBL] [Abstract][Full Text] [Related]
13. Effect of 1,25-dihydroxyvitamin D3 on the immunocompetent cells. Hoshino T; Iho S; Kura F Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):167-73. PubMed ID: 3487016 [TBL] [Abstract][Full Text] [Related]
14. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Kanatani M; Sugimoto T; Fukase M; Chihara K Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia]. Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067 [TBL] [Abstract][Full Text] [Related]
16. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
17. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
18. Regulation of 25-hydroxyvitamin D3 metabolism in cultures of osteoblastic cells. Letton RW; Fanti P; Malluche HH J Bone Miner Res; 1990 Aug; 5(8):815-23. PubMed ID: 2173357 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Müller K; Diamant M; Bendtzen K Immunol Lett; 1991 May; 28(2):115-20. PubMed ID: 1885209 [TBL] [Abstract][Full Text] [Related]
20. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)]. Kabitskaia OE; Savik ZF; Kaplanskiĭ AS; Shvets VN; Sergeev IN Kosm Biol Aviakosm Med; 1984; 18(4):49-55. PubMed ID: 6332944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]